首页> 外文期刊>Clinical ophthalmology >Safety, efficacy, and patient acceptability of lidocaine hydrochloride ophthalmic gel as a topical ocular anesthetic for use in ophthalmic procedures
【24h】

Safety, efficacy, and patient acceptability of lidocaine hydrochloride ophthalmic gel as a topical ocular anesthetic for use in ophthalmic procedures

机译:盐酸利多卡因眼用凝胶作为眼科手术局部用眼科麻醉剂的安全性,有效性和患者可接受性

获取原文
           

摘要

Purpose: To review the current literature on safety, efficacy, and measures of surgeon and patient satisfaction with lidocaine hydrochloride gel as a tool for ocular anesthesia.Methods: Pubmed search using keywords “lidocaine gel,” “ophthalmic,” and “surgery” and compiling cross-references. Twenty-six total references were reviewed, including 15 prospective randomized controlled trials (RCTs, total N = 933, average N = 62), 6 nonrandomized prospective studies (total N = 234, average N = 39), 2 animal studies, 1 microbiologic study, and 2 letters to the editor.Results: The RCTs and nonrandomized prospective studies evaluated a number of measures including timing of onset of anesthesia, duration of anesthesia, intraoperative and postoperative pain, need for additional anesthetic applications, intracameral lidocaine levels, and adverse effects. Control groups received topical drops, subconjunctival anesthetic, retrobulbar anesthetic, or sham gel. Lidocaine gel was shown to be at least as effective for pain control as alternative therapies in all studies, with longer duration of action than topical drops. Patient and surgeon satisfaction were high, and adverse effects were rare and comparable to those for anesthetic drop formulations. Surgical settings included cataract, pterygium, trabeculectomy, strabismus, intravitreal injection, vitrectomy, and penetrating keratoplasty.Conclusions: Lidocaine gel is a safe, effective, and potentially underutilized tool for ophthalmic surgery.
机译:目的:回顾当前有关利多卡因盐酸盐凝胶作为眼科麻醉工具的安全性,有效性和外科医生措施以及患者满意度的文献。方法:使用关键词“利多卡因凝胶”,“眼科”和“手术”进行公开搜索编译交叉引用。共审查了26篇参考文献,包括15项前瞻性随机对照试验(RCT,总N = 933,平均N = 62),6项非随机前瞻性研究(总N = 234,平均N = 39),2项动物研究,1项微生物学研究结果:RCT和非随机前瞻性研究评估了许多措施,包括麻醉开始的时间,麻醉的持续时间,术中和术后疼痛,需要额外麻醉的应用,前房内利多卡因水平和不良反应效果。对照组接受局部滴剂,结膜下麻醉剂,球后麻醉剂或假凝胶。在所有研究中,显示利多卡因凝胶在疼痛控制方面至少与替代疗法一样有效,并且作用持续时间长于局部滴剂。病人和外科医生的满意度很高,而且副作用很少,与麻醉滴剂的副作用相当。手术环境包括白内障,翼状,肉,小梁切除术,斜视,玻璃体内注射,玻璃体切除术和穿透性角膜移植术。结论:利多卡因凝胶是一种安全,有效且可能未被充分利用的眼科手术工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号